[Federal Register Volume 72, Number 243 (Wednesday, December 19, 2007)]
[Notices]
[Pages 71914-71915]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-24644]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH),
and Subcommittee for Dose Reconstruction Reviews (SDRR)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the CDC announces the following meeting
of the aforementioned committee and subcommittee:
Subcommittee Meeting Time and Date
10 a.m.-12:30 p.m., January 8, 2008
Advisory Board Meeting Times and Dates
1 p.m.-4:30 p.m., January 8, 2008
9:30 a.m.-5 p.m., January 9, 2008
8:30 a.m.-2:30 p.m., January 10, 2008
Public Comment Times and Dates
5 p.m.-6 p.m., January 8, 2008
7:30 p.m.-8:30 p.m., January 9, 2008
Place: Suncoast Hotel and Casino, 9090 Alta Drive, Las Vegas, NV
89145. Phone 702.636.7111, Fax 702.636.7050.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 75 to 100 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program (EEOICP) Act of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. Key functions of the Advisory Board include
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health and
Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final rule,
advice on the scientific validity and quality of dose estimation and
reconstruction efforts being performed for purposes of the compensation
program, and advice on petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2009.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters to be Discussed: The topics for the Subcommittee meeting
will include a Review of Individual Dose Reconstructions and future
Subcommittee Plans and Actions. The agenda for the Advisory Board
meeting includes: NIOSH Program Status Report; Redaction of Board
Transcripts and SEC Petition for Texas City Chemicals, Inc.; SEC
Petition for Nevada Test Site; SEC Petition for Mound; SEC Petition for
Combustion Engineering; SEC Petition for Lawrence Livermore National
Laboratory; SEC Petition Updates: Bethlehem Steel, Blockson, Chapman
Valve, Dow Chemical, Fernald, and Sandia; Science Issues Update;
Department of Labor Update; Department of Energy Update; FY08 Tasks for
Sanford Cohen & Associates; Update on selection of board support
contractor; NIOSH Program Update; Board Future Plans and Schedules;
Working Group Reports; and a Subcommittee for Dose Reconstruction
Reviews Report. The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted according the policy provided below. Any written comments
received will be provided at the meeting and should be submitted to the
contact person below well in advance of the meeting.
Policy on Redaction of Board Meeting Transcripts (Public Comment)
(1) If a person making a comment gives his or her name, no attempt
will be made to redact that name. (2) NIOSH will take reasonable steps
to ensure that individuals making public comment are aware of the fact
that their comments (including their name, if provided) will appear in
a transcript of the meeting posted on a public website. Such reasonable
steps include: (a) A statement read at the start of each public comment
period stating that transcripts will be posted and names of speakers
will not be redacted; (b) A printed copy of the statement mentioned in
(a) above will be displayed on the table where individuals sign up to
make public comment; (c) A statement such as outlined in (a) above will
also appear with the agenda for a Board Meeting when it is posted on
the NIOSH Web site; (d) A statement such as in (a) above will appear in
the Federal Register Notice that announces Board and Subcommittee
meetings. (3) If an individual in making a statement reveals personal
information (e.g., medical information) about themselves that
information will not usually be redacted. The NIOSH FOIA coordinator
will, however, review such revelations in accordance with the Freedom
of Information Act and the Federal
[[Page 71915]]
Advisory Committee Act and if deemed appropriate, will redact such
information. (4) All disclosures of information concerning third
parties will be redacted. (5) If it comes to the attention of the DFO
that an individual wishes to share information with the Board but
objects to doing so in a public forum, the DFO will work with that
individual, in accordance with the Federal Advisory Committee Act, to
find a way that the Board can hear such comments.
Contact Person for More Information: Dr. Lewis V. Wade, Executive
Secretary, NIOSH, CDC, 4676 Columbia Parkway, Cincinnati, Ohio 45226,
Phone 513.533.6825, Fax 513.533.6826.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: December 12, 2007.
Elaine L. Baker,
Director, Management Analysis and Services Office,Centers for Disease
Control and Prevention.
[FR Doc. E7-24644 Filed 12-18-07; 8:45 am]
BILLING CODE 4163-18-P